The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients

  • days left to enroll
  • participants needed
  • sponsor
    Danish Headache Center
Updated on 26 January 2021
calcitonin gene-related peptide


A randomized, double-blind, placebo-controlled, parallel study to investigate the effect of erenumab in calcitonin-gene related peptide and cilostazol experimental models of migraine in humans. Followed by a 6-month open-label extension.

Condition Migraine, Migraine (Pediatric), Migraine (Adult), Migraine with Aura, Common Migraine, Primary Stabbing Headache, Migraine and Cluster Headaches, Migraine (Adult), Migraine and Cluster Headaches, Migraine (Pediatric), migraines, migraine aura
Treatment Placebo, Cilostazol, Calcitonin Gene-Related Peptide, Erenumab
Clinical Study IdentifierNCT04452929
SponsorDanish Headache Center
Last Modified on26 January 2021


Yes No Not Sure

Inclusion Criteria

Patients with migraine with or without aura according to the International Classification of Headache Disorders with a frequency of 4 migraine days per month
-100 kg weight
Participants of childbearing potential must use safe contraception (birth control) or be sexually abstinent

Exclusion Criteria

Any other primary headache disorder according to the International Classification of Headache Disorders except for tension-type headache
Any secondary headache disorder according to the International Classification of Headache Disorders
Migraine attack during the preceding 48 hours on provocation day
Headache during the preceding 24 hours on provocation day
Treatment with monoclonal antibodies or participation in clinical trials with monoclonal antibodies during the preceding year
Daily consumption of any other drug/medication than oral contraception (birth control)
Consumption of any other drug/medication later than four times the plasma half-time of the drug on provocation day except for oral contraception
Pregnant or active breastfeeding participants
Any cardiovascular diseases including cerebrovascular disorders
Information in patient history or during physical examination indicating psychiatric disorders or substance abuse
Information in patient history or during physical examination that the screening physician deems relevant for participation in the study
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note